|
|
|
|
|
|
|
|
|
|
Patient organizations are moving beyond advisory roles to become active drivers of rare disease drug development. Join Craig Lipset and Dr. Derk Arts to explore how patient-led registries, natural-history data, real-world evidence, drug repurposing, and master protocols can help derisk clinical development. Discover what this emerging model looks like today, where its limits lie, and how clinical-development leaders can learn from early pioneers. Click here to learn more.
|
|
|
|
|
|
|
|
|
|
Five Preventable Clinical Design Pitfalls And How To Avoid Them
|
|
White Paper | By Ian Fisher, Keith McDonald, and Parvin Fardipour, Ph.D., IQVIA Safety & Regulatory Compliance
|
While late-stage trial attrition is often attributed to inadequate safety or efficacy, the true failure may be insufficient upstream planning and/or misalignment between clinical and commercial goals.
|
|
|
|
|
|
Making Informed Decisions In Your Oncology Study
|
|
Article | Worldwide Clinical Trials Oncology
|
Oncology biomarkers track tumor burden and reduce radiation from imaging. Composite algorithms improve response prediction. Fit-for-purpose strategies are needed to manage logistics and costs.
|
|
|
|
|
|
Replacing Manual Processes With RTSM Software
|
|
Case Study | Korio
|
Discover how a clinical-stage biotech automated its supply chain to protect patient enrollment and eliminate manual errors in a complex, multi-national genetic medicine trial.
|
|
|
|
|
|
The FSP Model Tailored For Biotech
|
|
E-Book | By Nithiya Ananthakrishnan and Monica Garvin, Precision for Medicine
|
As biomarker-driven trial designs and protocol complexity intensify, small and mid-sized sponsors face a growing gap between ambition and operational capacity that fragmented outsourcing can't close.
|
|
|
|
|
|
|
|
|
|
|
|
Clinical Innovations in AI: A Technology Showcase
|
Join us on September 10, 2026, at 10:00 AM ET for Clinical Innovations in AI, a virtual technology showcase exploring how AI is transforming clinical research. Leading innovators will demonstrate real-world solutions that help pharmaceutical and biotech sponsors streamline operations, improve decision-making, reduce trial burdens, and accelerate study execution. Discover emerging technologies, practical use cases, and opportunities to drive greater impact across the clinical trial lifecycle.
|
|
|
|
|
|
|
|
Can Digital Endpoints Really Accelerate Clinical Trials?
|
|
Guest Column | By Anita Burrell, principal, Anita Burrell Consulting LLC, Clinical Leader
|
Digital biomarkers are quickly and quietly becoming the digital revolution needed to make clinical trials quicker and more data rich. Discover how they are being used in clinical trials right now.
|
|
|
|
|
|
Decentralized Trials Still Need Connected Support
|
|
Guest Article/Blog | Scout
|
Decentralized and hybrid trials reduce travel burdens but add coordination challenges. Strong support improves communication, engagement, and smooth trial execution from enrollment to completion.
|
|
|
|
|
|
The Value Of Direct-To-Patient, Pharmacy-Led Solutions
|
|
Guest Article/Blog | Catalent
|
Pharmacy-led DTP models cut site burden, improve inventory control, and expand trial access. Learn how to optimize your decentralized trial supply chain for compliance and patient outcomes.
|
|
|
| Connect With Clinical Leader: |
|
|
|
|
